they have enough cash in the bank to get through stage one.
I think that it would be a shame to see Dr Melroses work get thrown aside by big pharma, and I believe the current staff feel the same way - especially James Graham. No chance they will sell out the IP. And with so many potential revenue streams, and with sepsis such a huge killer globally, I could easily see big pharma trying to work with recce instead
I would like to know how much volume the current production plant in Sydney can produce. I imagine it would be easy to set one up in the US if we work with big pharma there
they have enough cash in the bank to get through stage one. I...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |